Product Images Fenofibric Acid
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Fenofibric Acid NDC 33342-294 by Macleods Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
174 - fenofibric acid 135 mg 10x14s
This text appears to be a description of medication packaging for Fenofibric Acid Delayed-Release Capsules manufactured by Macleods Pharma USA. The capsules come in a packaging of 140 capsules (10 x 14 unit-doses) and each capsule contains 135 mg of fenofibric acid. It provides storage instructions to be kept at room temperature and protected from moisture. The medication is not child-resistant, and full prescribing information is available in the package insert.*
164 - fenofibric acid 135 mg 90s
Pharma USA offers Delayed-Release Capsules containing Fenofibric Acid, with each capsule equivalent to 135 mg of fenofibric acid. The packaging includes 90 capsules. It is essential to store the product at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) to maintain its integrity. The product includes warnings about not accepting the product if the seal is broken or missing. This pharmaceutical product is manufactured by Macleods Pharmaceuticals Ltd. in India and distributed by Macleods Pharma USA, Inc. It is crucial to keep this and all drugs out of the reach of children. Further prescribing information can be found in the package insert.*
163 - fenofibric acid 45 mg 10x10s
This is a description of a medication called Fenofibric Acid Delayed-Release Capsules in the strength of 45 mg. The medication comes in a pack of 100 capsules within 10 unit-doses. It is manufactured by Macleods Pharma in the USA and India. The capsules should be stored between 20°C to 25°C (68°F to 77°F) and protected from moisture. Additionally, the text advises keeping the medication out of reach of children and notes that the blister cards are not child-resistant.*
186 - fenofibric acid 45 mg 90s
This is a description of a medication called MACLEODD, which is a delayed-release capsule containing choline fenofibrate equivalent to 45 mg of fenofibric acid. It is manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. in India. The capsules should be store at 20° to 25°C (68° to 77°F) and protect from moisture. The package insert contains full prescribing information. It is important to keep this medication out of the reach of children and not accept if the seal over bottle opening is broken or missing.*
111 - fenofibric acid structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.